Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119168 · ClinicalTrials.gov registry record · Phase 4
Effect of Simethicone on Screening Colonoscopy
A Phase 4 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- Phase 4
- Development phase
- 268
- Enrollment target
NCT03119168: Completed Phase 4 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
NCT03119168 is a Phase 4 study that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 268 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03119168, a Phase 4 study, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 268 participants
- Enrollment target
Study Summary
This study is evaluating the effect of adding a high dose of simethicone to the standard polyethylene glycol preparation for screening colonoscopy in the quality of the preparation , adenoma detection rate and withdrawal times.
Primary Outcome
The number of adenomatous polyps removed at colonoscopy
Interventions
- DRUG Simethicone Solution
- OTHER Polyethylenglycol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2017-03-15 |
| Est. Completion | 2019-04-10 |
| Phase | Phase 4 |
What the finished NCT03119168 record still lists
NCT03119168 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 2 interventions - of which Simethicone Solution is the first listed.
NCT03119168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03119168 about?
NCT03119168 is a clinical study titled "Effect of Simethicone on Screening Colonoscopy". This study is evaluating the effect of adding a high dose of simethicone to the standard polyethylene glycol preparation for screening colonoscopy in the quality of the preparation , adenoma detection rate and withdrawal times.
What is the current status of trial NCT03119168?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 268 participants. The study started on 2017-03-15. Estimated completion is 2019-04-10.
What interventions are being tested in trial NCT03119168?
The interventions under investigation include: Simethicone Solution (DRUG), Polyethylenglycol (OTHER).
Who is sponsoring clinical trial NCT03119168?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03119168's enrollment target sits among peer trials
268 319th of 2000 higher than 1,681 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI